A Selenium‐Enriched Composite From Edible Mushrooms and Medicinal Plants Ameliorates Metabolic Disorders via Multi‐Target Network Modulation
Food Science & Nutrition · 2026-11 · 14 (11)
DOI: 10.1002/fsn3.72569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Science & Nutrition, online erschienen am 09.11.2026. Verfasst von Wuxian Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biology and Cultivation of Herb Medicine, Ministry of Agricultural and Rural Affairs Institute of Chinese Herbal Medicines, Hubei A…. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inspired by the dietary habits of centenarians in Enshi, China, this study developed two selenium‐enriched water‐soluble powder formulations (OFXBJC and NFXBJC) from edible mushrooms and medicinal plants. Comparison of their active components and metabolomic profiles showed that NFXBJC contained 39.0% higher total flavonoids, 33.4% higher total saponins, and 38.6% higher soluble protein, along with upregulated hypoglycemic metabolites. NFXBJC was therefore selected for subsequent evaluation of its effects on glucolipid disorders, renal injury, and hyperuricemia. In a Type 2 diabetic mouse model, low‐dose NFXBJC (80 mg/kg/day) dose‐dependently increased serum selenium levels, reduced fasting and postprandial blood glucose by 36.2% and 38.9%, respectively, lowered total cholesterol and triglycerides by 14.8% and 35.6%, respectively, and restored renal function without obvious organ toxicity. Correlation analysis revealed a strong negative association between blood glucose and serum selenium ( R 2 = 0.964). Network pharmacology identified 48 candidate compounds and 552 putative targets, with the top 10 hub targets (STAT3, IL6, AKT1, CTNNB1, TNF, EGFR, HIF1A, IL1B, SRC, and BCL2) fully conserved across diabetes, hyperlipidemia, and hyperuricemia, suggesting multi‐target modulation of a shared inflammation–metabolism network across these three conditions. Molecular docking further predicted stable binding of core active ingredients (e.g., cryptotanshinone, isorhamnetin, kaempferol) to these hub targets, with binding energies below −5.0 kcal/mol. An exploratory small‐scale human observational study suggested that NFXBJC may progressively reduce uric acid (32.2%–39.8%), blood glucose, and total cholesterol. Collectively, NFXBJC exerts beneficial effects on glucolipid metabolism, renal function, selenium status, and uric acid levels via multi‐target mechanisms, supporting its potential as a functional food for metabolic health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Biology and Cultivation of Herb Medicine, Ministry of Agricultural and Rural Affairs Institute of Chinese Herbal Medicines, Hubei Academy of Agricultural Sciences Enshi China.
- Zhejiang Key Laboratory of Chinese Medicine Modernization School of Pharmaceutical Sciences, Zhejiang Chinese Medical University Hangzhou China.
ORCID-Profile: Wuxian Zhou, Bo Zhu
Zitieren
APA
Zhou, W., Wang, F., Duan, Y., Jiang, X., Xiao, H., Yu, A., Kuang, H., Zhu, B., Wang, Q., & You, J. (2026). A Selenium‐Enriched Composite From Edible Mushrooms and Medicinal Plants Ameliorates Metabolic Disorders via Multi‐Target Network Modulation. Food Science & Nutrition, 14(11). https://doi.org/10.1002/fsn3.72569
Vancouver
Zhou W, Wang F, Duan Y, Jiang X, Xiao H, Yu A, et al. A Selenium‐Enriched Composite From Edible Mushrooms and Medicinal Plants Ameliorates Metabolic Disorders via Multi‐Target Network Modulation. Food Science & Nutrition. 2026;14(11). doi:10.1002/fsn3.72569
BibTeX
@article{Zhou2026,
author = {Zhou, Wuxian and Wang, Fanfan and Duan, Yuanyuan and Jiang, Xiaogang and Xiao, Hongchang and Yu, Aimin and Kuang, Hui and Zhu, Bo and Wang, Qingfang and You, Jingmao},
title = {A Selenium‐Enriched Composite From Edible Mushrooms and Medicinal Plants Ameliorates Metabolic Disorders via Multi‐Target Network Modulation},
journal = {Food Science & Nutrition},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/fsn3.72569}
}
EUVIMED